The Trulign toric accommodating posterior chamber IOL has been approved by the U.S. Food and Drug Administration, according to a news release from Bausch + Lomb.The lens, which corrects for astigmatism and can improve vision across a natural range of f…
LA JOLLA, Calif. — Minimally invasive vitrectomy effectively alleviated visual dysfunction induced by floaters while normalizing contrast sensitivity, according to a physician here.“These floaters have a significant impact on the quality of life, and we believe that it is by degradation of vision,” J. Sebag, MD, FACS, FRCOphth, FARVO, said at the American Ophthalmological Society meeting.
LA JOLLA, Calif. — The World Health Organization has recommended the SAFE strategy to help eliminate blinding trachoma by 2020, according to a physician here.“We are very excited that trachoma is on the radar screen, and we have hopes for 2020,” Sheila West, PhD, said at the American Ophthalmological Society meeting.
PARIS — Prophylactic use of intracameral cefuroxime during cataract surgery was not associated with increased macular thickening in the postoperative period, according to a study. Intracameral cefuroxime was shown in a large series to be highly effective in lowering the incidence of endophthlamitis following cataract surgery and was recommended as a routine prophylaxis by the French Agency for the Safety of Health Products, Geoffrey Dethorey, MD, said at the meeting of the French Society of Ophthalmology.
MILAN — Cataract surgery in patients previously implanted with iris-claw phakic lenses can lead to satisfactory visual outcomes with low induced astigmatism, according to one surgeon. Camille Budo, MD, presented his results from a series of 93 eyes of 63 patients who underwent cataract surgery at a mean interval of 8.9 years after implantation of iris-claw lenses at the annual joint meeting of Ocular Surgery News and the Italian Society of Ophthalmology. Iris-claw lenses previously implanted included the Artisan, Artiflex and toric Artisan lenses (Ophtec).
PARIS — IOLs specifically designed for microincision cataract surgery did not show an above-average incidence of posterior capsule opacification, according to a study. At the meeting of the French Society of Ophthalmology, Gilles Lesieur, MD, presented the analysis of a large series of 3,345 microincision cataract surgery (MICS) lenses. The series included the Akreos MICS (Bausch + Lomb) in 293 eyes, the CT Asphina (Carl Zeiss Meditec) in 558 eyes, the MicroSlim (PhysIOL) in 671 eyes and the Micro AY (PhysIOL) in 1,823 eyes.